Skip to content

Inpatient Obesity Intervention With Phone Follow-up

Inpatient Obesity: Can Weight Loss Intervention During Hospitalization Lead to Sustained Weight Loss at Six Months Following Discharge?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01920620
Enrollment
176
Registered
2013-08-12
Start date
2011-01-31
Completion date
2015-08-31
Last updated
2016-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, inpatient, intervention, weight loss

Brief summary

In this study we sought to determine whether inpatient weight loss counseling with post discharge phone follow-up would result in weight loss at six months. Secondary endpoints included weight change from baseline, changes in waist-to-hip ratios, assessment of weight perceptions and changes in patient reported health outcome measures. To our knowledge, this is the first randomized trial designed to evaluate the effects of an obesity intervention with post-discharge follow-up in an inpatient general medicine population.

Interventions

BEHAVIORALInpatient weight loss counseling

Weight loss counseling utilizing a 13 minute patient education video on weight loss and an 25 minute personalized health education session. Subjects set 3 specific behavior set three specific lifestyle goals prior to discharge including a calculated six month weight loss goal (10% of body weight) and specific dietary and fitness goals. Usual care group participants received no specific instruction regarding weight loss prior to discharge.

BEHAVIORALMotivational interviewing and troubleshooting via phone

All subjects were asked to track their weights over the 6 month duration of the study. Weights were obtained by phone at weeks 1,2,3,4, 8, 12, 16, 20 and 24. Phone calls for the intervention group utilized motivational and troubleshooting techniques whereas calls in the usual care group were used only to obtain weight and assess for changes in medications or health condition.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults ages 18-65 years old * Body mass index between 30-50 kg/m2 * Admitted to an internal medicine service

Exclusion criteria

* acute medical conditions known to affect weight (heart failure, cirrhosis, end-stage renal disease on dialysis, nephrotic syndrome, or pregnancy) * Charlson comorbidity index \>3 * moderate to severe major depression * prolonged steroid use (\>2 weeks) * initiation of medications known to affect weight * non-English speaking * precontemplation stage of change

Design outcomes

Primary

MeasureTime frame
Weight loss between groups6 months

Secondary

MeasureTime frame
Weight loss from baseline6 months
Change in Patient Reported Outcomes Measurement Information System (PROMIS) scores6 months
Change in waist-to-hip ratios6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026